title: The influence of nimodipine on hemodynamic parameters and peak and trough plasma concentrations of nifedipine chronically administered to elderly hypertensive patients.
abstract: Possible drug interactions between the two calcium channel blockers nimodipine and nifedipine were investigated in 12 elderly patients with stable mild to moderate hypertension. Their individually adjusted nifedipine treatment had been unchanged for at least 5 weeks. There was no evidence of significant changes in nifedipine efficacy as seen from blood pressure and heart rate after a 7-day comedication of 30 mg nimodipine t.i.d. as compared with the findings after combined administration of nifedipine and placebo. Nifedipine steady-state trough and peak concentrations were not significantly altered by concomitant nimodipine administration. On the other hand, nifedipine did not affect nimodipine trough and peak concentrations when compared with published data. Differences in clinical chemistry or tolerance between both treatment regimens did not occur or were marginal, respectively. In conclusion, a clinically relevant drug interaction between nifedipine and nimodipine which might be potentially harmful for patients with hypertension was not observed in this study.
authors.affiliation: AFB Klinische Pharmakologie GmbH, Berlin, Germany.
authors.forename: H P
authors.initials: HP
authors.lastname: Breuel
authors.forename: W
authors.initials: W
authors.lastname: Mück
authors.forename: P R
authors.initials: PR
authors.lastname: Heine
authors.forename: N
authors.initials: N
authors.lastname: Schmage
authors.forename: H
authors.initials: H
authors.lastname: Niklaus
authors.forename: J
authors.initials: J
authors.lastname: Kuhlmann
mesh_terms: D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D018592:Cross-Over Studies; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D004347:Drug Interactions; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D009553:Nimodipine / Q000494:pharmacology*; D011674:Pulse / Q000187:drug effects
chemical_list: D003692:Delayed-Action Preparations; D009553:Nimodipine; D009543:Nifedipine